We are live on ! Find out more
LS

Livforsakringsbolaget Skandia Portfolio holdings

AUM $2.58B
1-Year Est. Return 30.64%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+30.64%
3 Year Est. Return
+115.62%
5 Year Est. Return
+153.42%
10 Year Est. Return
+554.99%
AUM
$145M
AUM Growth
+$5.78M
Cap. Flow
-$1.43M
Cap. Flow %
-0.99%
Top 10 Hldgs %
23.91%
Holding
187
New
12
Increased
18
Reduced
17
Closed
19

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.22M
2
UTHR icon
United Therapeutics
UTHR
+$760K
3
F icon
Ford
F
+$723K
4
HUM icon
Humana
HUM
+$679K
5
CB icon
Chubb
CB
+$539K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.14M
2
BKI
BUCKEYE TECHNOLOGY INC
BKI
+$815K
3
CYH icon
Community Health Systems
CYH
+$741K
4
SFD
SMITHFIELD FOODS,INC
SFD
+$684K
5
CNO icon
CNO Financial Group
CNO
+$668K

Sector Composition

Rank Sector Weight
1 Healthcare 18.66%
2 Technology 17.87%
3 Financials 16.07%
4 Energy 13.85%
5 Consumer Staples 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUMN icon
151
Lumen
LUMN
$6.42B
$157K 0.11%
5,000
– –
MLKN icon
152
MillerKnoll
MLKN
$1.64B
$152K 0.11%
5,200
– –
SLM icon
153
SLM Corp
SLM
$5.27B
$152K 0.11%
17,079
– –
CAT icon
154
Caterpillar
CAT
$394B
$142K 0.1%
1,700
– –
DKS icon
155
Dick's Sporting Goods
DKS
$18.1B
$139K 0.1%
2,600
– –
SYK icon
156
Stryker
SYK
$132B
$135K 0.09%
2,000
– –
SNBR
157
DELISTED
Sleep Number
SNBR
$122K 0.08%
5,000
– –
CXT icon
158
Crane NXT
CXT
$2.96B
$111K 0.08%
5,182
– –
DK icon
159
Delek US
DK
$4.08B
$103K 0.07%
4,900
– –
AMKR icon
160
Amkor Technology
AMKR
$14.4B
$98K 0.07%
23,000
– –
ETN icon
161
Eaton
ETN
$177B
$80K 0.06%
1,162
– –
IPHS
162
DELISTED
Innophos Holdings, Inc.
IPHS
$80K 0.06%
1,521
– –
QCOM icon
163
Qualcomm
QCOM
$173B
$74K 0.05%
1,100
– –
SWBI icon
164
Smith & Wesson
SWBI
$638M
$62K 0.04%
+7,286
New +$63K
REGI
165
DELISTED
Renewable Energy Group, Inc.
REGI
$45K 0.03%
3,000
– –
MNK
166
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$40K 0.03%
+900
New +$39.5K
GLW icon
167
Corning
GLW
$144B
$38K 0.03%
2,600
– –
CVSA
168
Covista Inc
CVSA
$4.51B
$32K 0.02%
1,050
– –
CACI icon
169
CACI
CACI
$14.8B
– –
-4,600
Closed -$292K
CLF icon
170
Cleveland-Cliffs
CLF
$6.98B
– –
-9,700
Closed -$158K
CYH icon
171
Community Health Systems
CYH
$416M
– –
-19,118
Closed -$741K
EXC icon
172
Exelon
EXC
$47.1B
– –
-24,395
Closed -$537K
HRB icon
173
H&R Block
HRB
$6.69B
– –
-21,900
Closed -$608K
INTU icon
174
Intuit
INTU
$93.9B
– –
-2,900
Closed -$177K
KGC icon
175
Kinross Gold
KGC
$31.9B
– –
-25,700
Closed -$131K
4 5 6
7
8

Similar funds

GFA
Gallagher Fiduciary Advisors Rolling Meadows, Illinois $2.58B AUM 8.97% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
DCM
Dorsal Capital Management Redwood City, California $2.57B AUM 3.13% 1-Year Est. Return
PCM
Palestra Capital Management New York $2.57B AUM 29.93% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
GAG
GM Advisory Group Melville, New York $2.6B AUM 18.86% 1-Year Est. Return
ECP
Electron Capital Partners New York $2.55B AUM 87.77% 1-Year Est. Return
RCMF
RK Capital Management (Florida) Weston, Florida $2.6B AUM 83.27% 1-Year Est. Return

Livforsakringsbolaget Skandia's Q3 2013 Portfolio in Review

As of Q3 2013, Livforsakringsbolaget Skandia held 187 positions worth $145M, up 4.2% from $139M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Livforsakringsbolaget Skandia's Q3 2013 filing shows 12 new, 18 increased, 17 reduced and 19 closed positions. Its largest new stake was United Therapeutics: 10,403 shares worth $820K. The largest sale was Pfizer, an estimated $1.14M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Livforsakringsbolaget Skandia's largest Q3 2013 buy was United Therapeutics: 10,403 shares worth $820K.
  • Livforsakringsbolaget Skandia added most to ExxonMobil in Q3 2013, an estimated $1.22M increase.
  • Livforsakringsbolaget Skandia's biggest Q3 2013 reduction was Pfizer, cutting an estimated $1.14M.
  • Livforsakringsbolaget Skandia fully exited BUCKEYE TECHNOLOGY INC in Q3 2013, selling an estimated $815K.
  • Livforsakringsbolaget Skandia's ten largest holdings make up 24% of its $145M portfolio in Q3 2013.
  • Livforsakringsbolaget Skandia opened 12 new positions and closed 19 in Q3 2013.
  • Livforsakringsbolaget Skandia's portfolio value rose 4.2% quarter-over-quarter to $145M.

Based on Livforsakringsbolaget Skandia's 13F filing for Q3 2013, filed 16 Oct 2013.